🔴 Nautilus Biotechnology is trading 6.25% down today amid broad market and biotech-sector weakness

Nautilus Biotechnology is trading 6.25% lower at $2.02 amid a broad market sell-off and weaker biotech shares, though no direct cause is established.

• The Nasdaq is down 2.32% and the S&P 500 is down 1.25%; the biotech XBI sector is also lower.
• No clear company-specific catalyst emerged in the October 16 search. The October 27 earnings announcement is scheduled news, not an explanation for the decline.